1. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
   Carla M.M. Prado et al, 2009, Clinical Cancer Research CrossRef
2. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
   Mariusz Panczyk, 2014, World Journal of Gastroenterology CrossRef
3. Orotate Phosphoribosyltransferase Gene Polymorphism Predicts Toxicity in Patients Treated with Bolus 5-Fluorouracil Regimen
   Wataru Ichikawa et al, 2006, Clinical Cancer Research CrossRef
4. Uridine Diphosphate Glucuronosyltransferase (UGT) 1A1 and Irinotecan: Practical Pharmacogenomics Arrives in Cancer Therapy
   Peter J. O'Dwyer et al, 2006, Journal of Clinical Oncology CrossRef
5. Genetic Strategies to Individualize Supportive Care
   Howard L. McLeod, 2002, Journal of Clinical Oncology CrossRef
6. Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment
   Emma Dotor et al, 2006, Journal of Clinical Oncology CrossRef
7. Thymidylate Synthase Messenger RNA Expression in Plasma from Patients with Colon Cancer: Prognostic Potential
   Vanesa Garcia et al, 2006, Clinical Cancer Research CrossRef
8. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
   Laura Grumetti et al, 2022, Cancers CrossRef
9. Resveratrol as sensitizer in colorectal cancer plasticity
   Aranka Brockmueller et al, 2024, Cancer and Metastasis Reviews CrossRef
10. Role of Genomic Markers in Colorectal Cancer Treatment
    Wendy L. Allen et al, 2005, Journal of Clinical Oncology CrossRef
11. Loss of Heterozygosity at the Thymidylate Synthase ( TS ) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for a 28-bp Polymorphism in the TS Gene
    Kazumi Uchida et al, 2004, Clinical Cancer Research CrossRef
12. Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphism in Normal Tissue As Predictors of Fluorouracil Sensitivity
    Anders Jakobsen et al, 2005, Journal of Clinical Oncology CrossRef
13. Germline Genetic Testing to Predict Drug Response and Toxicity in Oncology— Reality or Fiction?
    Thomas IP Soh et al, 2011, Annals of the Academy of Medicine, Singapore CrossRef
14. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
    Amirsaeed Sabeti Aghabozorgi et al, 2020, World Journal of Gastrointestinal Oncology CrossRef
15. Thymidylate Synthase 5’ UTR Polymorphic Allele Distribution in South Florida Population
    Hiba Hammad et al, 2012, Journal of Cancer Therapy CrossRef